MX2009012349A - Compuestos de ((fenil)imidazolil)metilheteroarilo. - Google Patents

Compuestos de ((fenil)imidazolil)metilheteroarilo.

Info

Publication number
MX2009012349A
MX2009012349A MX2009012349A MX2009012349A MX2009012349A MX 2009012349 A MX2009012349 A MX 2009012349A MX 2009012349 A MX2009012349 A MX 2009012349A MX 2009012349 A MX2009012349 A MX 2009012349A MX 2009012349 A MX2009012349 A MX 2009012349A
Authority
MX
Mexico
Prior art keywords
methylheteroaryl
imidazolyl
phenyl
compounds
disclosed
Prior art date
Application number
MX2009012349A
Other languages
English (en)
Spanish (es)
Inventor
Ken Chow
Michael E Garst
Phong X Nguyen
Todd M Heidelbaugh
Santosh C Sinha
Smita S Bhat
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of MX2009012349A publication Critical patent/MX2009012349A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2009012349A 2007-05-14 2008-05-13 Compuestos de ((fenil)imidazolil)metilheteroarilo. MX2009012349A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91783307P 2007-05-14 2007-05-14
PCT/US2008/063489 WO2008141312A1 (en) 2007-05-14 2008-05-13 ((phenyl)imidazolyl)methylheteroaryl compounds

Publications (1)

Publication Number Publication Date
MX2009012349A true MX2009012349A (es) 2009-12-01

Family

ID=39683865

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012349A MX2009012349A (es) 2007-05-14 2008-05-13 Compuestos de ((fenil)imidazolil)metilheteroarilo.

Country Status (16)

Country Link
US (1) US20100273814A1 (enExample)
EP (1) EP2155715B1 (enExample)
JP (1) JP5323059B2 (enExample)
KR (1) KR20100031502A (enExample)
CN (1) CN101743240B (enExample)
AU (1) AU2008251324B2 (enExample)
BR (1) BRPI0811860A2 (enExample)
CA (1) CA2687303C (enExample)
DK (1) DK2155715T3 (enExample)
ES (1) ES2402746T3 (enExample)
IL (1) IL202137A0 (enExample)
MX (1) MX2009012349A (enExample)
NZ (1) NZ599554A (enExample)
RU (1) RU2478631C2 (enExample)
WO (1) WO2008141312A1 (enExample)
ZA (1) ZA200908088B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009091735A1 (en) * 2008-01-18 2009-07-23 Allergan.Inc Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
JP2019517524A (ja) * 2016-06-02 2019-06-24 パーデュー ファーマ エルピー 疼痛治療のための微量アミン関連受容体1アゴニスト及び部分アゴニスト
WO2024220941A1 (en) * 2023-04-21 2024-10-24 Alceptor Therapeutics, Inc. Triaryl agonists of alpha-2 adrenergic receptors
WO2024226608A2 (en) * 2023-04-25 2024-10-31 Aglaeapharma Inc. Imidazole containing compounds, derivatives therefore, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098811A (en) * 1988-09-22 1992-03-24 Minolta Camera Kabushiki Kaisha Ioner for developing electrostatic latent image comprising specified imidazoles
US5750720A (en) * 1996-03-28 1998-05-12 Ortho Pharmaceutical Corporation 4- (thien-3-yl)methyl!-imidazole analgesics
US6841684B2 (en) * 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
TWI283669B (en) * 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
BRPI0516025A (pt) * 2004-09-24 2008-08-19 Allergan Sales Inc 4-(heteroaril-metil e heteroaril-metil substituìda)-imidazol-2-tionas que atuam como agonistas alfa2 adrenérgicos

Also Published As

Publication number Publication date
JP2010527369A (ja) 2010-08-12
CN101743240B (zh) 2013-07-17
JP5323059B2 (ja) 2013-10-23
AU2008251324B2 (en) 2014-05-01
RU2009145817A (ru) 2011-06-20
WO2008141312A1 (en) 2008-11-20
AU2008251324A1 (en) 2008-11-20
CN101743240A (zh) 2010-06-16
EP2155715A1 (en) 2010-02-24
DK2155715T3 (da) 2013-05-13
IL202137A0 (en) 2010-06-16
BRPI0811860A2 (pt) 2014-11-18
US20100273814A1 (en) 2010-10-28
NZ599554A (en) 2013-12-20
EP2155715B1 (en) 2013-03-13
CA2687303A1 (en) 2008-11-20
KR20100031502A (ko) 2010-03-22
RU2478631C2 (ru) 2013-04-10
CA2687303C (en) 2015-05-05
ES2402746T3 (es) 2013-05-08
ZA200908088B (en) 2010-12-29

Similar Documents

Publication Publication Date Title
UA94833C2 (en) Substituted bicyclolactams
SG171617A1 (en) Therapeutic compounds
TN2010000102A1 (en) Novel fungicides
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
MY148703A (en) Polycyclic cinnamide derivatives
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
MY173448A (en) Phenyl and benzodioxinly substituted indazoles derivatives
GEP20135786B (en) Pyrrole compounds
TN2011000291A1 (en) Purine compounds
TN2011000172A1 (en) Therapeutic antiviral peptides
TW200745084A (en) Novel compounds
MX2009012125A (es) Compuestos terapeuticos.
MX2010004487A (es) Derivados lactamicos sustituidos y sus usos para glaucoma e hipertension ocular.
ATE506340T1 (de) 12-aryl-prostaglandin-analoga
TW200738627A (en) Trialkylsilyl-indoles
BRPI0716643A2 (pt) amidas terapêuticas e compostos relacionados
MY149400A (en) Bridged six-membered ring compounds
MX2009001578A (es) Lactamas terapeuticas.
WO2007146856A3 (en) Substituted gamma lactams as therapeutic agents
WO2008008700A3 (en) Substituted cyclopentane derivatives as therapeutic agents
NZ611169A (en) Pyrazole compounds having therapeutic effect on multiple myeloma
UA99840C2 (ru) Замещенные циклопентаны, которые имеют простагландиновую активность
MX2009012349A (es) Compuestos de ((fenil)imidazolil)metilheteroarilo.
MY152557A (en) 3-aminocyclopentanecarboxamides as chemokine receptor modulators

Legal Events

Date Code Title Description
FG Grant or registration